NURS 6630 Midterm Exam Test
Bank Questions and Answers
Neurotransmitter Systems - Answer-Multiple systems often dysfunction in psychiatric
illnesses.
Mood Disorder - Answer-Mental health condition affecting emotional state.
Bipolar III Disorder - Answer-Hypomanic episodes triggered by antidepressants.
5HT2A Antagonism - Answer-Serotonin receptor blocking aiding in EPS reduction.
Conventional Antipsychotics - Answer-First-generation antipsychotics with higher EPS
risk.
Second-Generation Antipsychotics - Answer-Newer antipsychotics with lower EPS risk.
Norepinephrine Targeting - Answer-Focus on norepinephrine for mood stabilization.
Bipolar I - Answer-Contraindicated for antidepressant monotherapy.
Bipolar II - Answer-Also contraindicated for antidepressant monotherapy.
Cyclothymia - Answer-Avoid antidepressants due to mood cycling risk.
SERT genotype - Answer-Influences SSRI/SNRI treatment response.
Norepinephrine - Answer-Affects serotonin levels in depression.
5HT release - Answer-Norepinephrine potentiates release via specific receptors.
NE neuron function - Answer-Drugs can mimic or inhibit NE neuron activity.
Residual symptoms - Answer-Include insomnia and concentration problems post-
treatment.
Fluoxetine (Prozac) - Answer-Increases serotonin by blocking presynaptic SERT.
SSRI action - Answer-Therapeutic effects linked to somatodendritic serotonin action.
Fluvoxamine vs Sertraline - Answer-Both effective in treating elderly depression.
,MAOI dietary restrictions - Answer-Avoid aged cheeses and fermented meats.
Bupropion - Answer-Previously ineffective in treating patient's depression.
Venlafaxine - Answer-Another ineffective antidepressant for the patient.
Antihistamines with MAOI - Answer-Caution required due to potential interactions.
Interdisciplinary treatment - Answer-Involves multiple specialties for comprehensive
care.
Major depressive disorder - Answer-Residual symptoms may persist despite treatment.
Serotonin - Answer-Neurotransmitter affected by antidepressant medications.
Antidepressant monotherapy - Answer-Not suitable for patients with bipolar disorders.
Mood cycling - Answer-Increased risk with certain antidepressant treatments.
Sedative-like effect - Answer-Common side effect of some antidepressants.
Withdrawal symptoms - Answer-Can include dizziness and restlessness.
Presynaptic receptors - Answer-Targeted by drugs to modulate neurotransmitter
release.
Symptoms - Answer-Indicators used to create a medical diagnosis.
Neuropharmacological regulation - Answer-Control of brain circuits by
neurotransmitters.
Treatment options - Answer-Strategies targeting symptoms for elimination.
Risk factors for depression - Answer-Conditions increasing vulnerability to depressive
disorders.
MAOI - Answer-Monoamine oxidase inhibitor, a type of antidepressant.
Dual therapy - Answer-Combination of two antidepressant medications.
Withdrawal symptoms - Answer-Physical or psychological effects from stopping
medication.
Abrupt discontinuation - Answer-Sudden stop of medication without tapering.
Fluoxetine - Answer-An SSRI used to treat depression and anxiety.
, Side effects - Answer-Unintended effects caused by medication.
Venlafaxine - Answer-An SNRI used for depression and anxiety.
Hepatic impairment - Answer-Reduced liver function affecting drug metabolism.
Milnacipran - Answer-Medication used to treat fibromyalgia.
Suicidality - Answer-Increased risk of suicidal thoughts or behavior.
Duloxetine - Answer-An SNRI contraindicated in certain medical conditions.
Sertraline - Answer-An SSRI used for panic disorder treatment.
Desvenlafaxine - Answer-An SNRI prescribed for major depressive disorder.
Tricyclic antidepressants (TCAs) - Answer-Older class of antidepressants with various
side effects.
Histamine H1 receptor blockade - Answer-Mechanism causing sedation and weight
gain.
BMI - Answer-Body Mass Index, a measure of body fat.
Muscarinic M1 receptor blockade - Answer-Causes blurred vision due to receptor
inhibition.
Alpha 1 adrenergic receptor blockade - Answer-Leads to weight gain as a side effect.
Muscarinic M3 receptor blockade - Answer-Results in sedation through receptor
inhibition.
MAO inhibitor - Answer-Requires dietary restrictions to avoid food interactions.
Soy products - Answer-Should be avoided by patients on MAO inhibitors.
Processed meats - Answer-Not safe for consumption with MAO inhibitors.
Fermented foods - Answer-Should be avoided due to tyramine content.
Pseudoephedrine - Answer-Decongestant that risks serotonin syndrome with MAO
inhibitors.
Serotonin syndrome - Answer-Potentially life-threatening condition from drug
interactions.
Bank Questions and Answers
Neurotransmitter Systems - Answer-Multiple systems often dysfunction in psychiatric
illnesses.
Mood Disorder - Answer-Mental health condition affecting emotional state.
Bipolar III Disorder - Answer-Hypomanic episodes triggered by antidepressants.
5HT2A Antagonism - Answer-Serotonin receptor blocking aiding in EPS reduction.
Conventional Antipsychotics - Answer-First-generation antipsychotics with higher EPS
risk.
Second-Generation Antipsychotics - Answer-Newer antipsychotics with lower EPS risk.
Norepinephrine Targeting - Answer-Focus on norepinephrine for mood stabilization.
Bipolar I - Answer-Contraindicated for antidepressant monotherapy.
Bipolar II - Answer-Also contraindicated for antidepressant monotherapy.
Cyclothymia - Answer-Avoid antidepressants due to mood cycling risk.
SERT genotype - Answer-Influences SSRI/SNRI treatment response.
Norepinephrine - Answer-Affects serotonin levels in depression.
5HT release - Answer-Norepinephrine potentiates release via specific receptors.
NE neuron function - Answer-Drugs can mimic or inhibit NE neuron activity.
Residual symptoms - Answer-Include insomnia and concentration problems post-
treatment.
Fluoxetine (Prozac) - Answer-Increases serotonin by blocking presynaptic SERT.
SSRI action - Answer-Therapeutic effects linked to somatodendritic serotonin action.
Fluvoxamine vs Sertraline - Answer-Both effective in treating elderly depression.
,MAOI dietary restrictions - Answer-Avoid aged cheeses and fermented meats.
Bupropion - Answer-Previously ineffective in treating patient's depression.
Venlafaxine - Answer-Another ineffective antidepressant for the patient.
Antihistamines with MAOI - Answer-Caution required due to potential interactions.
Interdisciplinary treatment - Answer-Involves multiple specialties for comprehensive
care.
Major depressive disorder - Answer-Residual symptoms may persist despite treatment.
Serotonin - Answer-Neurotransmitter affected by antidepressant medications.
Antidepressant monotherapy - Answer-Not suitable for patients with bipolar disorders.
Mood cycling - Answer-Increased risk with certain antidepressant treatments.
Sedative-like effect - Answer-Common side effect of some antidepressants.
Withdrawal symptoms - Answer-Can include dizziness and restlessness.
Presynaptic receptors - Answer-Targeted by drugs to modulate neurotransmitter
release.
Symptoms - Answer-Indicators used to create a medical diagnosis.
Neuropharmacological regulation - Answer-Control of brain circuits by
neurotransmitters.
Treatment options - Answer-Strategies targeting symptoms for elimination.
Risk factors for depression - Answer-Conditions increasing vulnerability to depressive
disorders.
MAOI - Answer-Monoamine oxidase inhibitor, a type of antidepressant.
Dual therapy - Answer-Combination of two antidepressant medications.
Withdrawal symptoms - Answer-Physical or psychological effects from stopping
medication.
Abrupt discontinuation - Answer-Sudden stop of medication without tapering.
Fluoxetine - Answer-An SSRI used to treat depression and anxiety.
, Side effects - Answer-Unintended effects caused by medication.
Venlafaxine - Answer-An SNRI used for depression and anxiety.
Hepatic impairment - Answer-Reduced liver function affecting drug metabolism.
Milnacipran - Answer-Medication used to treat fibromyalgia.
Suicidality - Answer-Increased risk of suicidal thoughts or behavior.
Duloxetine - Answer-An SNRI contraindicated in certain medical conditions.
Sertraline - Answer-An SSRI used for panic disorder treatment.
Desvenlafaxine - Answer-An SNRI prescribed for major depressive disorder.
Tricyclic antidepressants (TCAs) - Answer-Older class of antidepressants with various
side effects.
Histamine H1 receptor blockade - Answer-Mechanism causing sedation and weight
gain.
BMI - Answer-Body Mass Index, a measure of body fat.
Muscarinic M1 receptor blockade - Answer-Causes blurred vision due to receptor
inhibition.
Alpha 1 adrenergic receptor blockade - Answer-Leads to weight gain as a side effect.
Muscarinic M3 receptor blockade - Answer-Results in sedation through receptor
inhibition.
MAO inhibitor - Answer-Requires dietary restrictions to avoid food interactions.
Soy products - Answer-Should be avoided by patients on MAO inhibitors.
Processed meats - Answer-Not safe for consumption with MAO inhibitors.
Fermented foods - Answer-Should be avoided due to tyramine content.
Pseudoephedrine - Answer-Decongestant that risks serotonin syndrome with MAO
inhibitors.
Serotonin syndrome - Answer-Potentially life-threatening condition from drug
interactions.
